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Abstract Microsomal cytochrome b5 is a ubiqui-
tous, 15.2 kDa haemoprotein implicated in a number
of cellular processes such as fatty acid desaturation,
drug metabolism, steroid hormone biosynthesis and
methaemoglobin reduction. As a consequence of these
functionsthisproteinhasbeen consideredessential for
life. Most of the ascribed functions of cytochrome b5,
however, stem from in vitro studies and for this reason
wehavecarriedoutagermlinedeletionofthisenzyme.
We have unexpectedly found that cytochrome b5 null
mice were viable and fertile, with pups being born
at expected Mendelian ratios. However, a number of
intriguing phenotypes were identiﬁed, including
altered drug metabolism, methaemoglobinemia and
disrupted steroid hormone homeostasis. In addition to
these previously identiﬁed roles for this protein,
cytochromeb5nullmicedisplayedskindefectsclosely
resembling those observed in autosomal recessive
congenital ichthyosis and retardation of neonatal
development, indicating that this protein, possibly as
aconsequenceofitsroleinthedenovobiosynthesisof
unsaturated fatty acids, plays a central role in skin
developmentandneonatalnutrition.Resultsfromfatty
acid proﬁle analysis of several tissues suggest that
cytochrome b5 plays a role controlling saturated/
unsaturated homeostasis. These data demonstrate that
regional concentrations of unsaturated fatty acids are
controlled by endogenous metabolic pathways and not
by diet alone.
Keywords Cytochrome b5  Ichthyosis 
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Introduction
For more than 40 years microsomal cytochrome b5
has been proposed to modulate the activity of
cytochrome P450 enzymes, including those involved
in endogenous processes such as cholesterol and
steroid hormone synthesis/breakdown, as well as the
metabolism of exogenous xenobiotics, chemical
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2002; Borthiry et al. 2007; Kurian et al. 2006). The
modulation of P450 activity by cytochrome b5 is
reported to be both substrate- and P450-speciﬁc, with
evidence of both stimulation and inhibition of
substrate metabolism (Yamazaki et al. 2002; Schenk-
man and Jansson 2003). Cytochrome b5 has also been
described as a facilitator in the metabolism of
endogenous substrates such as the desaturation of
fatty acids (Jeffcoat et al. 1977) and methaemoglobin
reduction to haemoglobin (Jaffe 1981). Importantly,
for many of these pathways, cytochrome b5 has been
deemed obligatory and therefore by implication
possibly essential for life. However, as all the
evidence to date is drawn exclusively from in vitro
studies, the in vivo roles of this enzyme have thus
remained speculative.
In order to address the in vivo function of
microsomal cytochrome b5 in drug metabolism, we
have recently generated a mouse model (hepatic b5
null (HBN)) in which microsomal cytochrome b5 was
conditionally deleted in the liver (Finn et al. 2008).
HBN mice had signiﬁcantly reduced in vitro rates of
NADPH- and NADH-dependent metabolism of a
range of model substrates and probe drugs; further-
more, signiﬁcant changes in drug pharmacokinetics
were also found, demonstrating that cytochrome b5
does indeed play a signiﬁcant role in the in vivo
disposition of drugs.
A conditional approach was taken in these studies
because of the anticipation that complete deletion of
microsomal cytochrome b5 would be embryonic
lethal. However, as the functions of this protein have
been based on in vitro data, we also carried out germ
line deletion (b5 complete null (BCN)). Remarkably,
cytochrome b5 null animals were viable, fertile and
produced grossly normal pups at expected Mendelian
ratios. However, cytochrome b5 null mice exhibited a
number of unexpected and extraordinary phenotypes,
identifying new roles for this protein in skin lipid
homeostasis and neonatal development.
Materials and methods
Chemicals
Unless stated, all reagents were purchased from
Sigma–Aldrich (Poole, UK).
Cytochrome b5 complete null (BCN) mice
Homozygous cytochrome b5 complete knockout mice
(BCN, Cytb5
-/-) and control (wild-type, Cytb5
?/?)
mice were generated as previously described
(McLaughlin et al. 2010).
All mice were maintained on a standard chow
(RM1—Special Diet Services, Essex, UK) under
standard animal house conditions, with free access to
food and water, and 12 h light/12 h dark cycle. All
animal work was carried out in accordance with the
Animal Scientiﬁc Procedures Act (1986) and after
local ethical review.
Tissue histology
Skin sections were removed post mortem from the
backs of 10 week old male wild-type and BCN mice
(n = 3 for each genotype) and ﬁxed ﬂat on Whatman
3MM paper (GE Healthcare, Amersham, UK) in
formal saline (Gurr
 BDH, VWR International, Lut-
terworth, UK) before being sectioned and stained with
hematoxylin and eosin. Measurements were taken of
the epidermis,dermisand hair shaft thickness usingan
Olympus IX50 microscope (Olympus UK Ltd., Wat-
ford, UK) with Zeiss Axio Vision version 4.5 software
(Carl Zeiss Ltd., Welwyn Garden City, UK).
Thermal imaging
Thermal imaging experiments were performed in a
closed room at a constant temperature of 20C with
tolerance of 1C and lighting kept to a minimum.
This arrangement ensured temperature variations that
may adversely affect the performance of the thermal
camera were negligible. Temperature measurements
were obtained using a high-performance thermal
camera (Cedip Infrared Systems, France) containing
a 320 9 240 pixel focal plane array operating in the
mid-infrared range (3–5 lm) with a thermal sensi-
tivity of 0.02C and spatial resolution of 0.2 mm,
positioned 50 cm above the subject.
Body temperature measurements of 3 week old
male wild-type and BCN pups, (n = 3 for each
genotype) were taken at the same time of the day with
a 2-day interval over a period of 6 weeks to allow
temperature changes to be related to growth. In order
to determine skin temperature, a small area (20 mm
diameter) on the back of each mouse was shaved,
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123immediately before temperature measurements were
taken. Average and maximum temperatures of the
shaved and haired areas were calculated using the
specialized software associated with the camera
(Song et al. 2007).
Mouse milking
Nursing females (ﬁrst litter) were milked 10 days
postpartum. Brieﬂy, mice were given an i.p. injection
of oxytocin (100 ll, 5 U/ml) to simulate milk
production. After 20 min, treated mice were anes-
thetized by inhalation of isoﬂurane and milk produc-
tion facilitated by gentle squeezing of the nipples.
The milk released was collected by pipette and
samples were stored at -70C prior to analysis.
Lipid analysis
Detailed fatty acid proﬁle analysis was performed on
milk, plasma, skin and liver by the Nutrition Analyt-
ical Service, University of Stirling, UK, according to
thefollowingmethod.Totallipidswereextractedfrom
skin and liver by homogenising in 20 volumes of
chloroform/methanol (2:1 v/v) in an Ultra Turrax
tissue disrupter (Fisher Scientiﬁc, Loughborough,
UK). Total lipids were prepared from all samples
according to the Folch method and non-lipid impuri-
ties were removed by washing with 0.88% (w/v)
KCl (Folch et al. 1957). The weight of lipids was
determined gravimetrically after evaporation of the
solventandovernightdesiccationundervacuum.Fatty
acid methyl esters (FAME) were prepared by acid-
catalysedtransesteriﬁcationoftotallipidsaccordingto
the method of Christie (Christie 2003). Extraction and
puriﬁcation of FAME was performed as described by
Ghioni et al. (1996). FAME were separated and
quantiﬁed by gas–liquid chromatography using a
ThermoFisherTraceGC2000(ThermoFisher,Hemel
Hempstead,UK)equippedwithafusedsilicacapillary
column(ZBwax,30 m 9 0.32 mmi.d.;Phenomenex,
Macclesﬁeld, UK) with hydrogen as carrier gas and
using on-column injection. The temperature gradient
was from 50 to 150Ca t4 0 C/min and then to 195C
at 1.5C/min and ﬁnally to 220Ca t2 C/min.
Individual methyl esters were identiﬁed by compari-
son with known standards and by reference to
published data. Data were collected and processed
using the Chromcard for Windows (version 2.00)
computer package (Thermoquest Italia S.p.A.,
Milan, Italy).
Statistical analysis
Data sets were analyzed for statistical signiﬁcance
using an Unpaired student t-test (www.graphpad.
com/quickcalcs/ t-test1.cfm).
Results and discussion
Global deletion of microsomal cytochrome
b5 is not lethal
To establish the in vivo role(s) of microsomal
cytochrome b5 we generated a mouse germline dele-
tion of exons 2–5 of the gene. Mice lacking micro-
somal cytochrome b5, were unexpectedly viable, born
at expected Mendelian ratios and exhibited no gross
anatomical abnormalities. Cytochrome b5 complete
null (BCN) mice of both sexes were fertile, indicating
that cytochrome b5 is not necessary for sexual matu-
ration,demonstratingthatcytochromeb5doesnotplay
an obligatory role in testosterone biosynthesis (Akhtar
et al. 2005). However, analysis of testicular testoster-
one levels revealed that they were approximately
40%lowerinBCNmalesandthiswasaccompaniedby
the almost complete loss of the in vitro activity of
Cyp17, a P450 essential for testosterone biosynthesis
(McLaughlin et al. 2010). In addition to its role in
transferring electrons to P450s involved in the metab-
olism of steroids, cytochrome b5 can also act as an
electron donor to P450s involved in the metabolism of
drugs and foreign compounds. In agreement with our
previous ﬁndings in the conditional hepatic knockout
model, BCN mice also had a marked reduction in in
vivoP450drugmetabolismconﬁrmingthepivotalrole
this protein may play in drug metabolism in vivo (Finn
et al. 2008; McLaughlin et al. 2010).
Cytochrome b5 is thought to play a key role in the
reduction of methaemoglobin to haemoglobin (Jaffe
1981) and in agreement with this role, 10 week old
male BCN mice had signiﬁcantly higher levels of
circulating methaemoglobin (tenfold) than their wild-
type counterparts (Fig. S1). Methaemoglobinemia in
humans is clinically deﬁned as having methaemoglo-
bin levels greater than 1%, with homozygous meth-
aemoglobin reductase-deﬁcient patients possessing
Transgenic Res (2011) 20:491–502 493
123levels greater than 10% (Percy et al. 2005). By this
deﬁnition, BCN mice are methaemoglobinemic,
however none of the other physiological phenotypes
associated with methaemoglobinemia due to disrup-
tion of cytochrome b5 or cytochrome b5 reductase in
humans were observed (Hegesh et al. 1986; Giordano
et al. 1994; Manabe et al. 1996). These data suggest
that although cytochrome b5 is part of the pathway of
methaemoglobin reduction, the known alternative
pathways such as the glucose/glucose-6-phosphate
dehydrogenase are capable of partially compensating
for loss of this protein and maintaining methaemo-
globinemia at asymptomatic levels (Jaffe 1981). BCN
mice may, however, be more susceptible to acquired
methaemoglobinemia under conditions of metabolic
stress or to chemicals known to induce methaemo-
globinemia (Molthrop et al. 1994; Mary and Bhupa-
lam 2000).
Together these ﬁndings conﬁrm in vivo the
numerous functions assigned to microsomal cyto-
chrome b5 through in vitro studies carried over the
past four decades.
Deletion of microsomal cytochrome b5 results
in the development of ichthyosis
Ten days after birth hair growth had commenced in
wild-type mice but in contrast BCN pups remained
hairless and exhibited a generalized scaling of the skin
andhyperkeratosis onthe tail which by4 weeksofage
resulted indevelopmentofconstrictivebands, referred
toas ‘ringtail’,a condition observedinrats kept indry,
low humidity environments (Fig. 1a, b). At 4 weeks,
the hair coat of BCN mice had developed a ‘‘static’’
appearance and was noticeably thinner than in age-
matched controls (Fig. 1c). By 10 weeks of age coat
condition had improved further however, the differ-
ence in thickness compared to wild-type mice could
still be clearly seen on the ventral surface (Fig. 1d).
Microscopic examination of hair types from BCN and
wild-type mice found no signiﬁcant difference in the
absolute numbers or proportion of each hair type
between the two genotypes (data not shown). These
data therefore suggest that deletion of microsomal
cytochrome b5 delays hair follicle development.
Histological examination of dorsal skin sections
from 10 week old male wild-type (Fig. 1e, g) and
BCN (Fig. 1f, h) mice identiﬁed pronounced kerat-
inization of the stratiﬁed squamous epithelium in the
latter and concomitant signiﬁcant thickening of the
epidermis—13.2 lm ± 0.6 versus 10.2 lm ± 0.3
(Fig. 1, compare e & f). Furthermore, hair shaft width
was signiﬁcantly ﬁner in BCN mice than in wild-type
animals(12.7 lm ± 0.09vs.14.7 lm ± 0.3;Fig. 1i).
Similar increases in epidermal thickness and keratini-
zation have been reported on disruption of the 12R-
lipoxygenase, ALOX12B locus, in mice, an enzyme
involved in an alternative pathway of arachidonic acid
metabolism in the skin, and suggests that cytochrome
b5 may also contribute to this pathway of eicosanoid
biosynthesis (Juanes et al. 2009). The skin phenotypes
observed in BCN mice are highly similar to those
observed in the human diseases classed as autosomal
recessive congenital ichthyosis (ARCI) (Akiyama and
Shimizu 2008).
A static hair phenotype has also been observed in
stearoyl-CoA desaturase (SCD1) null mice (Miyazaki
et al. 2001). However, in SCD1 null mice, the effect
is associated with atrophy of the sebaceous glands, as
a result of lipid depletion, whereas in BCN mice the
sebaceous glands were slightly enlarged (Fig. 1g, h).
Also, the characteristic phenotypes associated with
ichthyosis have not been reported for SCD1 null
mice. These data therefore suggest a role for cyto-
chrome b5 in lipid and eicosanoid metabolism in skin,
disruption of which leads to the development of
ichthyosis. Ichthyosis was not reported in the meth-
aemoglobinemia patient identiﬁed by Hegesh et al.
who expressed a splice variant of cytochrome b5;
however this is most likely due to the presence of
residual cytochrome b5 expression/activity and not
complete loss as in BCN mice (Hegesh et al. 1986;
Giordano et al. 1994).
Cytochrome b5 is essential for skin lipid
homeostasis but its deletion does not disrupt
epidermal barrier function
In light of the above data, we carried out fatty acid
analysis of the skin. Signiﬁcant changes in the levels
of most saturated, monounsaturated and branched-
chain fatty acid species, many of which are known to
have emollient and moisturizing properties e.g.
behenic and erucic acid, were observed in the skin
of 10 week old male BCN mice (Table S1). In
addition, signiﬁcant changes in the levels of a-
linolenic acid (decreased by 35%) and eicosadienoic
acid (increased by 40%) were found (Table S1).
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unsaturated to saturated fatty acids), as a measure of
SCD activity (Attie et al. 2002), for both palmitic and
stearic acid showed a 50 and 54% reduction, respec-
tively, in BCN compared to wild-type mice (Fig. 2a).
This may account for some of the similarities
observed between BCN and SCD1 null mice. The
skin phenotype of SCD1 null mice was ascribed to
the disruption of the epidermal lipid barrier, due to
loss of x-hydroxylated very long chain fatty acids
and the abolishment of lymphoid enhancer-binding
factor 1 (lef1) expression, a transcription factor
essential for correct development of the hair follicle
and the sebaceous gland; however, in agreement with
the morphological differences of the sebaceous gland
between BCN and SCD1 null mice, lef1 expression
levels are not signiﬁcantly changed in 10 week old
male BCN mice (data not shown) (Binczek et al.
2007; DasGupta and Fuchs 1999). Members of the
CYP4 family function in lipid metabolism as x-
hydroxylases, acting on long-chain fatty acids and
Loughran et al. have showed that cytochrome b5 is
essential for the in vitro x-hydroxylation of arachi-
donic acid (Hardwick 2008; Kalsotra and Strobel
2006; Loughran et al. 2001). The skin phenotypes
observed in BCN mice may therefore result from a
Fig. 1 Characterization of skin related phenotypes from
cytochrome b5 null mice. a 10 day old wild-type and BCN
pupsillustratingthescaledappearanceofBCNpups.bA4 week
old BCN mouse demonstrating the ‘‘ringtailed’’ phenotype.
c Age-matched (4 weeks) wild-type (left) and BCN mice
demonstrating the differences in coat appearance/condition
andthesmallersizeoftheBCNmice.dVentralviewof10 week
old male BCN (left) and wild-type mice demonstrating marked
thinning of the hair. e, g Hematoxylin and eosin staining of skin
from 10 week old male wild-type mice, magniﬁcation 209 &
409, respectively. f, h Hematoxylin and eosin staining of skin
from 10 week old male BCN mice, magniﬁcation 209 &
409, respectively. Arrows indicate the sebaceous glands
(e–h) and the keratinization of the stratiﬁed squamous epithe-
lium(f—asteriskedarrow)inBCNmice.iMeasurementsofhair
shaft width, epidermal and dermal thicknesses in 10 week old
male BCN and wild-type mice. Values represent the
mean ± SD of 50 measurements from each mouse (n = 3).
Black and white bars represent wild-type and BCN mice
respectively. * P B 0.05, ** P B 0.005, *** P B 0.001 com-
paring wild-type and BCN mice
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biosynthesis and a reduction in the x-hydroxylation
of long-chain fatty acids. In support of this possibil-
ity, Lefe ´vre et al. have identiﬁed mutations in the
gene FLJ39501, a member of the CYP4F subfamily,
associated with lamellar ichthyosis (Lefevre et al.
2006).
Approximately 30% of ARCI cases cannot be
explained by genetic changes in known ichthyosis
loci; the data presented here suggest that polymor-
phisms in the cytochrome b5 pathway represent novel
candidate genes for study. The striking similarities
between the BCN phenotype and the human disease
suggest that the BCN mouse could potentially be a
valuable genetic model for developing new treat-
ments for this disease and suggest new approaches for
therapeutic intervention.
The loss of the epidermal lipid barrier in the skin
of SCD1 null mice has been associated with pertur-
bations in temperature control (Binczek et al. 2007),
we therefore used thermal imaging to assess whether
the changes in skin fatty acids observed in BCN mice
also resulted in disruption of this barrier. A small
patch of back hair was shaved on 3 week old male
BCN and wild-type mice to allow skin surface
temperature measurements to be recorded together
with similar measurements from haired regions over a
6 week period (Fig. 2b, c). In shaved skin areas,
despite signiﬁcantly higher measurements at two (out
of 18) time-points, no overall difference between
BCN and wild-type mice in either average or
maximum temperatures was detected over the 6 week
period (Fig. S2). In contrast, BCN mice had consis-
tently signiﬁcantly higher average and maximum
temperatures in the haired skin areas compared to
wild-type mice over the entire 6 week period,
however from 5 to 6 weeks of age the differences
in both average and maximum temperatures between
genotypes decreased and the trend was for these
measurement to approach those recorded for wild-
type mice (Fig. 2d, e). These data indicated that the
heat losses observed in BCN mice are primarily due
Fig. 2 Characterization of skin lipid and temperature changes
in cytochrome b5 null mice. a Total lipid content and
desaturation indices determined from skin fatty acid proﬁle
analysis carried out on 10 week old male wild-type and BCN
mice. Values represent the mean ± SD, where n = 3 for wild-
type mice and n = 6 for BCN mice. b and c Thermal imaging
of 4 week old male wild-type and BCN mice respectively.
Temperature measurements were recorded from in 3 week old
wild-type and BCN mice for a period of 6 weeks as outlined in
the ‘‘Materials and methods’’. d Average temperature and
e maximum temperature of the haired coat area plotted against
age. Values represent the mean ± SD, where n = 3. Black and
white squares represent wild-type and BCN mice respectively.
* P B 0.05, ** P B 0.005, *** P B 0.001 comparing wild-
type and BCN mice
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epidermal barrier permeability and conﬁrm the visual
observations that coat thickness improved with age in
BCN mice.
Disruption of mammary gland cytochrome b5
activity identiﬁes roles in the determination
of milk composition and neonatal development
As indicated by the thermal imaging data, the
changes in coat condition, possibly associated with
the changes in skin lipid composition, improved as
the mice mature, however coat condition did start to
deteriorate again with age and especially in nursing
females. In nursing females, this led to hair loss with
skin reddening, particularly under the chin, around
the eyes and snout, with the birth of each subsequent
litter (Fig. 3a, b). Post-weaning, the dams’ coat
condition recovered and the skin inﬂammation sub-
sided. Associated with these effects, pups from
successive BCN litters were progressively smaller
(unlike wild-type) suggesting the possibility that the
dams’ milk was nutritionally deﬁcient (Fig. 3c, d).
This hypothesis was supported by the ﬁnding that the
Fig. 3 Cytochrome b5 null mice nurturing phenotype. a and
b Progressive loss of coat condition in BCN females with
successive litters. Arrows indicate the development of dry, red
and inﬂamed skin under the chin (a); dry skin around eyes and
muzzle, and poor coat condition accompanied by hair loss (b).
c Age-matched (23 days old) BCN (left) and wild-type
weanlings from the third litter of the relevant homozygous
cross, showing the marked difference in size. d Time course of
average litter weights for sequential litters from wild-type
(upper panel) and BCN (lower panel). Black squares, triangles
and circles represent wild-type litters 1, 2 and 3, respectively,
while white squares, triangles and circles represent BCN litters
1, 2 and 3, respectively. Values represent the mean ± SEM.
e Fostering of 3 day old wild-type pups (third litter) to a BCN
mother and BCN pups (second litter) to a wild-type mother
indicates growth retardation is due to nutrient deﬁciencies.
f Growth curves for wild-type pups left with their wild-type
mother (black squares), BCN pups fostered to the wild-type
mother (white squares), wild-type pups fostered to a BCN
mother (black circles) and BCN pups left with their BCN
mother (white circles). Values represent the mean ± SEM. of
n = 4–6. * P B 0.05, comparing BCN pups fostered to a wild-
type mother and BCN pups left with their BCN mother.
a P B 0.05 and b P B 0.005, comparing wild-type pups
fostered to a BCN mother and wild-type pups left with their
wild-type mother
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signiﬁcantly reduced the growth retardation. In
contrast, when wild-type pups were nursed by a
BCN female a striking reduction in growth was
observed (Fig. 3e, f).
The possibility that BCN milk is deﬁcient in
essential nutrients was investigated by comparing the
fat content of milk taken 10 days postpartum from
nursing wild-type and BCN females (both nursing
their ﬁrst litter). BCN milk contained a signiﬁcantly
higher level of total lipid; the predominant change
being an increase in total saturated fatty acid levels;
consistent with the role of cytochrome b5 in fatty acid
desaturation (Fig. 4a, Table S2). However, a small
increase in n-6 polyunsaturated fatty acids was also
observed. Monounsaturated and n-3 polyunsaturated
fatty acid content was unchanged. The increase in
saturated fat was associated with an increase in lauric,
myristic, palmitic and arachidic acid (increased by 72,
75, 56 and 67% respectively) and the increase in n-6
polyunsaturated fats was due speciﬁcally to a 32%
(P = 0.021) increase in linoleic acid (Fig. 4b). In
addition, the level of a-linolenic acid was signiﬁcantly
increased in BCN milk although total n-3 polyunsat-
urated fatty acid levels were unchanged (Fig. 4b).
Under normal circumstances the level of fat
contained in milk is tightly regulated but the com-
position can change depending on the maternal diet
and circulating levels of individual fatty acids (Innis
2007; Rudolph et al. 2007). Genetic disruption of
lactogenesis or lipogenesis, for example through the
inactivation of the a-lactalbumin gene or of the
activity of the mammary Akt pathway, has however
been shown to increase the fat content of milk
resulting in increased viscosity (Stinnakre et al. 1994;
Schwertfeger et al. 2003). This has been suggested in
both these situations to prevent pups obtaining
sufﬁcient qualities of milk to support normal growth
and thus leading to growth retardation. Indeed, milk
from BCN mice appeared to have increased viscosity
which would be consistent with the increase in
saturated fat content and could possibly lead to an
inability of BCN pups to obtain sufﬁcient nutrition to
support normal growth. Cytochrome b5 may therefore
be an important determinant in regulating the
consistency of milk by virtue of its role in controlling
fatty acid desaturation in the mammary gland.
However, we believe that the underlying reason for
the reduced growth is due to a metabolic deﬁciency
rather than a nurturing issue as the phenotype was
progressive in subsequent generations. In addition to
dietary intake, polyunsaturated fatty acids such as
arachidonic, docosahexaenoic and eicosapentaenoic
acid can be synthesised from linoleic and a-linolenic
acid via the actions of D5 and D6 desaturases in
maternal tissues. These desaturases have been shown
to be expressed in lactating mammary glands of rats
and are active in the conversion of linoleic acid to the
c-linolenic and arachidonic acid (Rodriguez-Cruz
et al. 2006). Additionally, the in vitro ﬁndings of
Guillou et al. have shown that exogenously added
cytochrome b5 is capable of enhancing D6 desaturase
activity (Guillou et al. 2004). The loss of desaturase
activity could explain the increase in linoleic acid in
the milk; humans genetic variations in these gene loci
have been associated with altered polyunsaturated
fatty acid levels in milk (Xie and Innis 2008). It is
therefore possible that the changes in the levels of
linoleic and a-linolenic acid in BCN milk are respon-
sibleforthegrowthretardationobservedinBCNpups.
Fig. 4 Milk fatty acid proﬁle analysis from wild-type and
cytochrome b5 null mice. Fatty acid proﬁle analysis was carried
out on milk from wild-type and BCN females nursing their ﬁrst
litters 10 days postpartum. a Total and b individual fatty acid
levels. Values are presented as fold change relative to wild-
type levels and represent the mean ± SD, where n = 3.
* P B 0.05, ** P B 0.005 and *** P B 0.001 comparing
wild-type and BCN mice
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excess levels of these fatty acids result in postnatal
growth restriction (Bongiovanni et al. 2007; Church
et al. 2008). The animals used in this study were on a
normal diet, nutritionally balanced for saturated and
unsaturated fatty acids. It is therefore intriguing that in
spite of this, defects in endogenous unsaturated fatty
acid biosynthesis caused the above phenotypes. The
progressive degradation in the health of dams, sug-
gests that an equilibrium exists between circulating
fattyacidsandbreastmilk,butthatthisisnotsufﬁcient
to reverse the nutritional deﬁciency.
Disruption of microsomal cytochrome b5 provides
evidence for a central role in mono
and polyunsaturated fatty acid homeostasis
In support of the role of cytochrome b5 in overall
fatty acid homeostasis, we found that in 16 week old
male BCN mice the plasma level of c-linolenic acid
was signiﬁcantly decreased (by 75%) and that of
dihomo-c-linolenic acid increased (by 153%)
(Fig. 5a, Table S3). Additionally, in these mice,
hepatic levels of these fatty acids followed a similar
pattern with c-linolenic acid decreased by 84% and
dihomo-c-linolenic acid increased by 195% (Fig. 5b,
Table S4). Furthermore, hepatic levels of octadeca-
tetraenoic acid were decreased by 80% and eicosa-
tetraenoic acid increased from undetectable levels to
0.03 ± 0.01 mg/g tissue (Fig. 5b). These fatty acids
correspond to the substrates and products of various
reactions catalysed by the D5 and D6 desaturases
(Napier et al. 2003), and the differences observed in
the desaturation indices for these fatty acids provides
evidence for cytochrome b5 as a modulator of the
activity of these enzymes (Fig. 5c, d). In view of the
effects ascribed to dietary x-3 and x-6 fatty acids on
human health, it is important to understand the role of
the endogenous biosynthetic pathways on circulating
levels of these unsaturated fatty acids.
Monounsaturated fatty acids can be obtained either
from the diet or by de novo synthesis involving a
cytochrome b5-dependent pathway (Hackett and
Strittmatter 1984; Schenkman and Jansson 2003).
We therefore determined saturated and monounsatu-
rated fatty acid levels in plasma and liver from 10 and
16 week old male BCN mice (Tables S3, S4). At
16 weeks of age profound differences in both plasma
Fig. 5 Hepatic and plasma
fatty acid proﬁle analysis in
wild-type and cytochrome
b5 null mice. Fatty acid
proﬁle analysis was carried
out on plasma and livers
from 16 week male old
wild-type and BCN mice as
described in the ‘‘Materials
and methods’’. a Plasma
fatty acid analysis, b liver
fatty acid analysis, c plasma
desaturation indices and
d liver desaturation indices.
Values are presented as fold
change relative to wild-type
levels and represent the
mean ± SD, where n = 3.
* P B 0.05, ** P B 0.005
and *** P B 0.001
comparing wild-type and
BCN mice
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123and hepatic levels of stearic (increasing by 50 and
47%,respectively)andpalmitoleicacid(decreasingby
34 and 52%, respectively) were observed (Fig. 5a, b).
Plasma and hepatic levels of palmitic and oleic acid
were effectively unchanged and only the hepatic level
of palmitoleic acid was signiﬁcantly changed at
10 weeks of age (Table S4). Determination of desat-
uration indices for both palmitic and stearic acid
revealed decreases for both fatty acids in BCN mice;
however, only the desaturation index for palmitic acid
was signiﬁcantly changed (Fig. 5c, d). These data
demonstrate that under normal dietary conditions
cytochrome b5-dependent pathways affect circulating
mono and polyunsaturated fatty acid concentrations
andtheiractivitywillthereforeinﬂuencethebeneﬁcial
effects of these compounds. Interestingly, Zhu et al.
have recently identiﬁed a cytochrome b5/b5 reductase
fusion protein, NAD(P)H cytochrome b5 oxidoreduc-
tase (Ncb5OR), located in the lumen of the endoplas-
mic reticulum, which when deleted in mice results in
marked decreases in hepatic levels of palmitoleic and
oleic acid, suggesting a role for this protein in electron
transporttoSCD1(Zhuetal.2004;Laradeetal.2008).
In summary, we have generated a novel genetic
model that identiﬁes the numerous and varied in vivo
roles of cytochrome b5 and now allows these
pathways to be studied in detail. Using this model
we have identiﬁed that cytochrome b5 plays a key
role in a wide range of metabolic processes of central
importance to both nutrition, drug metabolism and a
range of human diseases and further demonstrate the
importance of de novo unsaturated fatty acid biosyn-
thesis in human health (McLaughlin et al. 2010).
With the exception of the changes in hepatic lipid
metabolism, none of the other phenotypic changes
observed in BCN mice are seen in the conditional
hepatic knockout model (Finn et al. 2008). This
ﬁnding indicates that these phenotypic changes are
most likely due to the speciﬁc absence of cytochrome
b5 in the particular tissue and not to the systematic
disruption of cytochrome b5 function, a fact that
would also explain, with the exception of plasma and
hepatic fatty acid changes which mimic each other,
the differences in fatty acid proﬁles obtained from
different tissues. These studies also demonstrate that
certain endogenous pathways of fatty acid homeo-
stasis cannot be substituted by dietary means. The
relationship between de novo biosynthesis and die-
tary intake of fatty acids and how dietary intervention
may inﬂuence the pathogenesis of human disease will
be a fascinating area of further study.
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